[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 18 days · First seen · Last updated

Fresenius share sale and capital allocation

Overview

Fresenius SE & Co. KGaA announced an agreement to sell approximately 7.8 million shares of Fresenius Medical Care to selected institutional investors. The transaction, valued at roughly €300 million, represents about 2.9 percent of the dialysis provider’s issued share capital.

Following the sale, Fresenius will retain a 25 percent stake in Fresenius Medical Care. The company plans to use the net proceeds to reduce group net debt and increase strategic flexibility for its ‘#FutureFresenius’ transformation. Fresenius expects to report a book gain in the low to mid-double-digit millions of euros as a special item in the third quarter.

Entities

Fresenius SE & Co. KGaA · Michael Sen · Klaus Röhrig · Gerresheimer AG · Fresenius Medical Care

Timeline

  1. 19 days ago

    [BUSINESS] 2 sources
    Fresenius and Gerresheimer report significant share acquisitions

    Michael Sen of Fresenius SE & Co. KGaA and Active Ownership Opportunities SCS have both reported significant share acquisitions in their respective companies.

  2. about 1 month ago

    [BUSINESS] 4 sources
    Fresenius to sell €300 million in Fresenius Medical Care shares

    Fresenius is selling 7.8 million shares of Fresenius Medical Care for approximately €300 million to increase strategic flexibility and fund growth platforms.

Sources

biotech-investments.com · finanzen.at · finanzen.ch · finanznachrichten.de